ReoPro (abciximab) to inhibit blood clotting

January 1996

You'll see more cardiologists using ReoPro (abciximab) to inhibit blood clotting.

This biotech anti-platelet drug came out earlier this year. It's for patients undergoing balloon angioplasty...to help keep the dilated artery open.

So far it's only approved for high-risk patients. But now there's evidence of an overwhelming benefit in reducing MI and death...even after routine cases of angioplasty.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote